Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rxo (RXO) Gross Profit (2021 - 2025)

Rxo (RXO) has disclosed Gross Profit for 5 consecutive years, with $266.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit fell 14.19% year-over-year to $266.0 million, compared with a TTM value of $1.1 billion through Dec 2025, up 14.82%, and an annual FY2025 reading of $1.1 billion, up 14.82% over the prior year.
  • Gross Profit was $266.0 million for Q4 2025 at Rxo, down from $284.0 million in the prior quarter.
  • Across five years, Gross Profit topped out at $322.0 million in Q2 2022 and bottomed at $214.0 million in Q1 2024.
  • Average Gross Profit over 5 years is $266.1 million, with a median of $276.0 million recorded in 2021.
  • The sharpest move saw Gross Profit decreased 25.47% in 2023, then soared 31.91% in 2024.
  • Year by year, Gross Profit stood at $276.0 million in 2021, then increased by 0.72% to $278.0 million in 2022, then decreased by 15.47% to $235.0 million in 2023, then surged by 31.91% to $310.0 million in 2024, then dropped by 14.19% to $266.0 million in 2025.
  • Business Quant data shows Gross Profit for RXO at $266.0 million in Q4 2025, $284.0 million in Q3 2025, and $301.0 million in Q2 2025.